Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

100.89
-0.6411-0.63%
Post-market: 100.32-0.5741-0.57%19:08 EDT
Volume:413.93K
Turnover:41.72M
Market Cap:1.61B
PE:9.40
High:101.91
Open:101.51
Low:100.34
Close:101.53
52wk High:108.66
52wk Low:69.02
Shares:16.00M
Float Shares:16.00M
Volume Ratio:3.00
T/O Rate:2.59%
Dividend:1.47
Dividend Rate:1.45%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Apollo in Advanced Talks to Acquire Johnson \u0026 Johnson's Orthopedics Unit in Deal Valued Near $20B

Stock News
·
Sep 12

J&J Orthopedics Unit Draws Apollo Interest in Potential $20 Billion Deal, Bloomberg News Reports

Reuters
·
Sep 12

Apollo Global is Said in Talks to Acquire J&J’s Orthopedics Unit - Bloomberg News

THOMSON REUTERS
·
Sep 12

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
Sep 12

DBS Keeps Their Buy Rating on Merck & Company (MRK)

TIPRANKS
·
Sep 12

Tylenol Maker, Pharmacy Chains Urge US Appeals Court to Revisit Decision over Alleged Autism Link

Reuters
·
Sep 12

Eli Lilly Stock (LLY) in Focus as Company Completes $3.8 Billion AtaiBeckley Purchase

TIPRANKS
·
Sep 11

Eli Lilly Completes Acquisition of AtaiBeckley

Reuters
·
Sep 11

Lilly Completes Acquisition of Ataibeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions

THOMSON REUTERS
·
Sep 11

Berenberg Lifts Price Target on Merck to $137 From $127, Keeps Hold Rating

MT Newswires Live
·
Sep 11

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

TIPRANKS
·
Sep 11

MS Cuts Novo Nordisk on Growth Prospects, Patent Expiry Risks

Reuters
·
Sep 11

Growth Without AI: 8 Stock Picks

Dow Jones
·
Sep 11

Top Bristol-Myers Squibb Executive Makes Major Move With Insider Stock Sale

TIPRANKS
·
Sep 11

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Bristol Myers’ EVP, Chief Medical Officer Cristian Massacesi Disposes of 6,249 Common Shares Worth $403,700.93

Reuters
·
Sep 11

Champions Oncology Q1 Revenue Rises on Research Services Business

Reuters
·
Sep 11

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Reuters
·
Sep 11

Revolution Medicines Got a 'Miracle' Cancer Drug Approval. Wall Street Wants More.

Dow Jones
·
Sep 11

Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings

Dow Jones
·
Sep 11